{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:14:58Z","timestamp":1651212898054},"reference-count":3,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.juro.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T12:43:56Z","timestamp":1533905036000},"page":"943-944","source":"Crossref","is-referenced-by-count":0,"title":["Re: Frequent PD-L1 Expression in Primary and Metastatic Penile Squamous Cell Carcinoma: Potential Opportunities for Immunotherapeutic Approaches"],"prefix":"10.1097","volume":"200","author":[{"given":"Sam S.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2018.08.005_bib1","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.juro.2017.01.059","article-title":"Penile cancer: contemporary lymph node management","volume":"197","author":"O\u2019Brien","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.08.005_bib2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.juro.2015.03.090","article-title":"Establishing criteria for bilateral pelvic lymph node dissection in the management of penile cancer: lessons learned from an international multicenter collaboration","volume":"194","author":"Zargar-Shoshtari","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.08.005_bib3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.juro.2016.01.003","article-title":"Re: Treatment for metastatic penile cancer after first-line chemotherapy failure: analysis of response and survival outcomes","volume":"195","author":"Chang","year":"2016","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718436762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718436762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2018.08.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:41:03Z","timestamp":1651210863000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2018.08.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":3,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1016\/j.juro.2018.08.005"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2018.08.005","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}